PuraPharm Corporation Limited (HKG:1498)
0.3300
-0.0050 (-1.49%)
At close: Feb 13, 2026
PuraPharm Corporation Revenue
PuraPharm Corporation had revenue of 172.30M HKD in the half year ending June 30, 2025, a decrease of -11.68%. This brings the company's revenue in the last twelve months to 346.76M, down -17.32% year-over-year. In the year 2024, PuraPharm Corporation had annual revenue of 382.09M, down -6.09%.
Revenue (ttm)
346.76M
Revenue Growth
-17.32%
P/S Ratio
0.51
Revenue / Employee
739.36K
Employees
469
Market Cap
176.57M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 382.09M | -24.77M | -6.09% |
| Dec 31, 2023 | 406.86M | -41.21M | -9.20% |
| Dec 31, 2022 | 448.07M | -211.52M | -32.07% |
| Dec 31, 2021 | 659.59M | 57.78M | 9.60% |
| Dec 31, 2020 | 601.82M | -94.06M | -13.52% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shenzhen Neptunus Interlong Bio-technique Company | 1.09B |
| Kontafarma China Holdings | 891.73M |
| Wai Yuen Tong Medicine Holdings | 721.27M |
| Qianhai Health Holdings | 553.58M |
| Tianda Pharmaceuticals | 310.50M |
| Fusen Pharmaceutical Company | 264.08M |
| Sanai Health Industry Group Company | 104.88M |
| Extrawell Pharmaceutical Holdings | 52.65M |